Bihui Meng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Bihui Meng has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Haiyan Yang
The Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China
1 shared publication - Haiyang Zhou
Endocrinology
1 shared publication - Jia Zhou
Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China
1 shared publication - Shurong Lu
The Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China
1 shared publication - Song Huang
The Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China
1 shared publication - Xinghuan Liang
Department of Endocrinology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
1 shared publication
Latest Publications
- Open Access
- 8 November 2018
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 18 (1) , 82
Complicated Gitelman syndrome and autoimmune thyroid disease: a case report with a new homozygous mutation in the SLC12A3 gene and literature review
Gitelman syndrome (GS) is an inherited autosomal recessive renal tubular disorder characterized by low levels of potassium and magnesium in the blood, decreased excretion of calcium in the urine, and elevated blood pH. GS is caused by an inactivating mutation in the SLC12A3 gene, which is located on the long arm of chromosome 16 (16q13) and encodes a thiazide-sensitive sodium chloride cotransporter (NCCT). A 45-year-old man with Graves’ disease complicated by paroxysmal limb paralysis had a diagnosis of thyrotoxic periodic paralysis for 12 years. However, his serum potassium level remained low despite sufficiently large doses of potassium supplementation. Finally, gene analysis revealed a homozygous mutation in the SLC12A3 gene. After his thyroid function gradually returned to normal, his serum potassium level remained low, but his paroxysmal limb paralysis resolved. GS combined with hyperthyroidism can manifest as frequent episodes of periodic paralysis; to date, this comorbidity has been reported only in eastern Asian populations. This case prompted us to more seriously consider the possibility of GS associated with thyroid dysfunction.
- 8 November 2018
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 18 (1) , 82
Open AccessComplicated Gitelman syndrome and autoimmune thyroid disease: a case report with a new homozygous mutation in the SLC12A3 gene and literature review
Gitelman syndrome (GS) is an inherited autosomal recessive renal tubular disorder characterized by low levels of potassium and magnesium in the blood, decreased excretion of calcium in the urine, and elevated blood pH. GS is caused by an inactivating mutation in the SLC12A3 gene, which is located on the long arm of chromosome 16 (16q13) and encodes a thiazide-sensitive sodium chloride cotransporter (NCCT). A 45-year-old man with Graves’ disease complicated by paroxysmal limb paralysis had a diagnosis of thyrotoxic periodic paralysis for 12 years. However, his serum potassium level remained low despite sufficiently large doses of potassium supplementation. Finally, gene analysis revealed a homozygous mutation in the SLC12A3 gene. After his thyroid function gradually returned to normal, his serum potassium level remained low, but his paroxysmal limb paralysis resolved. GS combined with hyperthyroidism can manifest as frequent episodes of periodic paralysis; to date, this comorbidity has been reported only in eastern Asian populations. This case prompted us to more seriously consider the possibility of GS associated with thyroid dysfunction.